New Jersey attracts more venture capital investment than in 2007

04/04/2013
Diego Gutiérrez
New Jersey attracts more venture capital investment than in 2007

New Jersey is known as "The Garden State". The reason for that name is not known for certain, but one thing that has certainly flourished is the amount of money invested by venture capitalists in the Healthcare sector in the state. According to the PitchBook Platform, venture capitalists have invested a total of $3.27 billion in New Jersey-based companies since the beginning of 2007, 58% of which was poured into Healthcare companies.

The "Pharmaceuticals and Biotechnology" sub-sector has been the main contributor to the lively investment activity in New Jersey. This sub-sector alone accounted for 46% of the venture capital funds received in the State over the same time period.

Hello products: an example from New Jersey Healthcare

Hello productsa developer of oral hygiene products, has received funding led by lfrom Tenth Avenue Holdings (TAH)with the participation of William Morris Endeavor and  Harmony Partnersamong others. The companys Montclair, New Jersey, company offers a product line that includes toothbrushes, toothpaste, mouthwashes and respiratory sprays. The new capital will be used to invest in proprietary packaging, inventory, marketing and business development, as well as new product development and sales expansion. As part of the transaction, TAH Co-CEOs Citron Joel and Laurence Denihan will join the Hello board of directors.

Lastest news

Webinar | How much does your business depend on you?

INFORMACIÓN IMPORTANTE: La inscripción y participación en los webinars es totalmente anónima para terceros Si durante un mes no pudieras intervenir en las decisiones importantes, ¿qué pasaría en tu empresa? Tu compañía puede crecer, ser rentable y tener buenos...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?